Posts Tagged ‘elderly patients’

Prescription Pill-Popping By Far a Leading Killer as Florida’s Drug Deaths Spike 20%

Thursday, July 1st, 2010

FlaglerLive.Com
July 1, 2010

Oxycodone, the addictive prescription pain-killer also known by its Purdue Pharma brand name OxyContin, directly caused more deaths in Florida in 2009 than cocaine, heroin and morphine combined. Prescription drugs as a whole are killing far more Floridians than illegal drugs, with some 8,600 deaths last year involving at least one prescription drug, according to an annual report released today by the Florida Medical Examiners Commission.

That’s 5 percent of all deaths in Florida in 2009, when 171,300 people died in the state.

The number of people killed by prescription drugs is a significant 20 percent increase over last year’s 6,200 deaths attributed to overdoses. Much of the increase is due to a spike in oxycodone addiction. The increase in prescription-drug addiction continues a trend that began in Florida 10 years ago, when prescription drugs overtook illegal drugs as leading causes of drug-related deaths.

Alcohol is also included in the examiners’ analysis, and it leads the way of all drug-related deaths, with 4,046.

The annual report is a stark look at the effects of legalized drug addiction and over-prescription of drugs, both of which affect a far larger segment of the population than recreational or illegal narcotics.

For the first time in 2009, the commission tracked deaths by region. In Flagler County’s district, which includes St. Johns and Putnam counties, 22 deaths were attributed to oxycodone (the fourth lowest number in the state’s 23 districts), with 13 of those deaths directly attributed to the drug, and nine cited as being present among other drugs that contributed to death.

Hydrocodone claimed 16 lives in the district. Cocaine contributed to 19 deaths in the Flagler district, though only four cases were directly attributed to the drug. In 15 cases, cocaine was present in the body in conjunction with other drugs that proved lethal. Overall in Florida, cocaine-related deaths (including the majority of cases where cocaine wasn’t directly the factor but was present in the body at the time of death), have fallen from a peak of 2,179 in 2007 to 1,462 in 2009. (Again, cocaine was the direct result of death in 529 cases out of those).

Ken Kramer, a researcher with the Citizens Commission on Human Rights of Florida, says the numbers underestimate the extent of the problem, because medical examiners do not track deaths attributed to antipsychotic drugs or to antidepressants, both of which carry black-box or black-label warnings. The warnings on antidepressants, required by the Food and Drug Administration, state that the drugs increase the risk of suicidal thinking and behavior in children, adolescents and young adults up to age 24. (Antidepressants include Paxil, Prozac, Zoloft, Effexor, Lexapro and Celexa.)

Anti-psychotic drugs carry a variety of black label warnings of increased mortality in elderly patients (including a death rate almost twice as high for people taking Risperdal, for example). Those drugs, prescribed and often overprescribed in nursing homes and assisted living facilities, include Abilify, Clozaril, Geodon, Risperdal, Seroquel and Zyprexa.

“Certainly, the actual number of prescription drug deaths is higher than the annual report states,” Kramer said. “It is unknown just how much higher because the Medical Examiners Commission does not track these classes of drugs.”

Two years ago Kramer got his concern heard by the commission following an email exchange with a commissioner in which he argued that antidepressants and anti-psychotic drugs’ contributions to mortality should be part of the annual report. He was rebuffed. One examiner vsaid he had not seen “more than the occasional death caused by these types of drugs,” according to the minutes of the Aug. 13, 2008 meeting of the commission.

Read entire article:  http://flaglerlive.com/7256/florida-prescription-drugs-deaths-oxycontin-oxycodone

« Return to news items


Share

Antidepressants Linked to Blindness in Older Adults

Tuesday, June 8th, 2010

Main Street
By Althea Chang
June 8, 2010

Antidepressant use could be linked to blindness in older adults, a recent study suggests.

Drugs that treat depression known as selective serotonin reuptake inhibitors, or SSRIs, caused an increased risk of developing cataracts in patients aged 65 or older, according to a study published in the journal Ophthalmology in June.

Researchers said cataracts may be more likely to develop in patients using this specific type of depression medication because serotonin receptors are found in the lens of the eye, according to MedPage Today.

Cataracts occur when the ocular lens gets cloudy and causes vision loss and even blindness. According to the World Health Organization, cataracts are responsible for 48% of age-related blindness cases worldwide.

While the elderly are generally more prone to developing cataracts than the population as a whole, researchers said they adjusted their study results to consider blood pressure, use of other medications and gender among the 200,000 people involved.

Read entire article:  http://www.mainstreet.com/article/family/family-health/antidepressants-linked-blindness

« Return to news items


Share

Science Daily: Almost 1/3 of U.S. nursing home residents received antipsychotic drugs as chemical restraints

Wednesday, June 2nd, 2010

Illinois Nursing Home Abuse Blog
By Levin & Perconti

Science Daily is reporting that a study shows that newly admitted elderly patients to nursing homes have a higher rate of being prescribed antipsychotic drugs than in previous years. This study found that in 2007, almost one-third of U.S. nursing home residents received antipsychotic drugs. The FDA has issued a warning that there is a great risk of death among older adults with dementia who are taking these agents to control behavioral symptoms. A recent clinical trial has concluded that the adverse effects of atypical antipsychotic drugs have outweighed the benefits of those with Alzheimer’s. This shows that many doctors are over prescribing these drugs, and it is having an adverse effect on patients.

The nursing home study found that about 30 percent of the residents in the study received at least one antipsychotic medication in 2006 and 32 percent of those did not have dementia or another indication that they needed to be on this medication. Some experts believe that the organizational culture of the nursing homes may encourage the prescribing of antipsychotic. Hopefully, the FDA warning and other studies will move the prescription statistics in the opposite direction. If not policies may have to target those nursing homes that have a high antipsychotic prescription rate so as to improve patient care. To read more about the nursing home study, please click the link.

Read entire article:  http://blog.levinperconti.com/2010/05/antipsychotic_medications_are.html

« Return to news items


Share

Australia’s growing drug problem—Elderly overprescribed antidepressants

Friday, May 21st, 2010

The University of Queensland, Australia
May 21, 2010

Older Australians are being overprescribed medications for depression, according to a study by University of Queensland researchers published today in the Australian and New Zealand Journal of Psychiatry.

Dr Samantha Hollingworth, Senior Research Fellow at the School of of Population Health, said the study found very high prescribing rates in older Australians, especially those over 85 years old despite national mental health data indicating that depression and anxiety was a decreasing problem in this age group.

“While the under 50s have a higher prevalence of depression and anxiety, it is the over 85s who are receiving the most medication,” Dr Hollingworth said.

The study found that the prevalence and treatment of depressive and anxiety disorders are highest in those aged under 50, after which it declines rapidly. There are peaks in prescribing of antidepressants in those aged in their late 50s and early 90s, with the highest use in those aged 90-94 years.

Co-author, Professor Harvey Whiteford, Kratzmann Professor of Psychiatry and Population Health with the Queensland Centre for Mental Health Research, said it appeared older Australians were receiving antidepressant medications for reasons other than the treatment of conditions for which these drugs have marketing approval, or for depressive and anxiety symptoms that do not reach the threshold for a diagnosis.

Read entire article:  http://www.uq.edu.au/news/?article=21193

« Return to news items


Share

Massachusetts joins federal lawsuit accusing Johnson & Johnson of paying kickbacks to push their antipsychotic drug

Thursday, March 11th, 2010

Fierce Pharma
By Tracy Staton
March 11, 2010

The Massachusetts attorney general joined that federal lawsuit accusing Johnson & Johnson of paying kickbacks to push the antipsychotic Risperdal and other drugs into nursing homes. AG Martha Coakley didn’t stop there; however, her office is also investigating other companies that market antipsychotics to nursing homes in the state.

At issue is whether drug companies are touting antipsychotic drugs for unapproved uses, such as dementia. The FDA has warned that use of the atypical antipsychotics in elderly dementia patients can increase the risk of death. “The inappropriate off-label marketing of antipsychotic drugs to nursing homes is a significant health and safety issue for our seniors,” Coakley says in a statement released by her office (as quoted by the Boston Globe). “We have taken strong action on this issue in the past and are continuing to monitor it very closely moving forward.”

Read entire article:  http://www.fiercepharma.com/story/massachusetts-joins-kickback-suit-against-j-j/2010-03-11

« Return to news items


Share

Scandalous abuse of the elderly: 100,000 prescribed antipsychotics that double risk of death/triple risk of stroke

Monday, February 8th, 2010

The Daily Telegraph
By Rebecca Smith
February 7, 2010

Tens of thousands of vulnerable dementia patients are being prescribed ‘chemical cosh’ drugs in hospital wards in a ‘scandalous abuse’ of the elderly, ten leading health organisations have said in a letter to The Daily Telegraph.

Three quarters of nurses have seen people with dementia in general wards in hospital prescribed antipsychotic drugs that are known to double the risk of death and triple the risk of a stroke in these patients, research has shown.

It is the first time the scale of the abuse in hospital wards is exposed, following warnings that 100,000 dementia patients in care homes are prescribed the drugs leading to the deaths of 23,000 a year.

Ten leading charities, carers groups and experts have written to The Daily Telegraph saying: “We cannot stand by while this scandalous abuse of vulnerable citizens continues.”

Neil Hunt, Chief Executive of Alzheimer’s Society said: “The massive over prescription of antipsychotics to people with dementia is an abuse of human rights, causing serious side effects and increasing risk of death. These powerful drugs should only be used in a small number of cases. The Government must take action to ensure that these drugs are only ever used as a last resort.”

They have called on the government to publish its long-overdue review of the use of antipsychotics which ministers promised would be out in May of this year.

Read entire article:  http://www.telegraph.co.uk/health/healthnews/6264962/Scandalous-abuse-of-the-elderly-prescribed-antipsychotics-in-hospital-exposed.html

« Return to news items


Share